Latkin Jed 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Aug 18, 2020
Insider Transaction Report
Form 4
Latkin Jed
Interim COO
Transactions
- Award
Common Stock
2020-08-14$0.00/sh+50,000$50→ 107,997 total - Award
Stock Option
2020-08-14$0.00/sh+100,000$100→ 100,000 totalExercise: $4.70Exp: 2030-08-14→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest as to one-third on each of July 1, 2021, July 1, 2022 and July 1, 2023.
- [F2]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of July 1, 2021, July 1, 2022 and July 1, 2023.